{"name":"E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.","slug":"e-nitiate-biopharmaceuticals-hangzhou-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPMHpITkR5enRaOGh0YlREQmxkUDdKOER2LUZUNnFjbGdEbC0zMUp5ODE4QjU0SVF5M3pac0dmUjE2UGg1a3ZKM281VDQyaTRmRTQ1X3dNanFOa2JNLW1iWGJ1c21uNDRyZG8xQ1daTmMtd0lwekZCTkQzZVpkUHE4dG1RLU55MDZMNmNPV0lrLW43ZEZ1OG12ekV1VnYyVEpKcE5LYmhLdnVQbV9JOXd3cnlCVS13OXJGeWp3OGo3MA?oc=5","date":"2026-03-17","type":"pipeline","source":"Nasdaq","summary":"Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight - Nasdaq","headline":"Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gJBVV95cUxOWElpTmp1Zkd5ZVVBT0Z5c1BrNUl6dEYzQVJaTi1WYnl1YndNQU1kZlkxMjlsbERWaU1YdW5YUXhDaWljeTk4NnBDbXJRQUdmM1lOWk1iaGJLbDB6NklNWUNzOTRGdmMyOGc1TXpJTmt4SG9kelhUN0p4djI0dE9MRFVncmpzZHRVU0tjSHV0WG5vUzJuUUtMcE11ZWZfSlNjazBGVkg0QUkyWFNiMW9jNFNUUjlrQzA5YzljZEh5eUxySmZlVFpmWlVpZlo1VEM3anFpRGg5UnZyTlFKVjlib0xZMVdqcThRTE1GU3M5djdLMGk2cFUwX3VwdWxVY3o3dFQ3WXFudGF4VjVvTVJia1B0NGt5bW5La2xnZVJ5VzVKMEg4VmF6US16OEsyZkgyUnJ0TVRpQlBhMHFseUNuZmpfTlJIdWstMGlYMXZZbHFJWXZnQVE?oc=5","date":"2026-03-16","type":"regulatory","source":"Barchart.com","summary":"Psoriasis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | AnaptysBio, Nimbus Lakshmi, Takeda, MoonLake Immunotherapeutics, Can-Fite Biopha","headline":"Psoriasis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPd2p4RHowNHR3Y3VRTVJRLXE4VnhTN2hZZFBBUGV4RjFsUXp0UlZXQ3d4V2hyM2xFM1FEeWx2Z1FaTWVBV2k5SjVneGVGbVg3cFowMzlwRklPMDZSS01pTWJiQUE5TkRqcUN5emdzSjdXUnFwZlB1ZG80cllvdGpUMTBYenRWN0EtV1VWUUlnbDV6VVdBTlNWcg?oc=5","date":"2026-02-16","type":"pipeline","source":"Financial Times","summary":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight – Company Announcement - FT.com - Financial Times","headline":"Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5nOHZ3Sm5pVTY0NTY1UVR4blVyZnRwWXBfRHZxOEE5QmQxY0JRTlZJTkhieUxlLVVlaDAwbGRBdVJZQVJHS1B5MUtUelJ0SUlBb2RV?oc=5","date":"2025-12-23","type":"pipeline","source":"Failory","summary":"Top 70 Hangzhou Startups to Watch in 2026 - Failory","headline":"Top 70 Hangzhou Startups to Watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"GlobeNewswire","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - GlobeNewswire","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQd3FBTE9tSFhFOG1MMTJyZDNuSFc4aHdYY1paY0RYN0pGdXdKZF9KMG9XdWJoS3d6QnFjTVF3QUhBTjZYcEV6TEdrUUREcjF0Sjk0TTIwbzF3UDN3bk9BNmpPSGh1bEhRMmJRTUxJM0s0T3lKeEFTcVFGSVVqbTVoT1EzbzhpdVhzOUtldW8wTmtUdw?oc=5","date":"2025-05-20","type":"trial","source":"Yahoo Finance","summary":"Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight - Yahoo Finance","headline":"Moderate to Severe Atopic Dermatitis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQSXVyMU1FWUQzVUNXcjB3bWJCMEtJaFB1SEUtLXd4YkpBVXo0OFVuWTZsVHVHUDRVaUtZVFAwaUVYdkdIRjZWNUVKR00tT21XU2toeWFRLUktc1YzZUtIcDBGUWpEdUxneEFUdlBEMFlkV0pPc0g3SThkRnNfYUZ0dDlISUZxeVZ5UnVYRjRUeWFyNDJESVVsdlVJQ2FsS0dua3hwaVpoVQ?oc=5","date":"2022-09-20","type":"pipeline","source":"BioWorld News","summary":"E-nitiate Biopharma raises $14.4M to develop drugs for dermatosis - BioWorld News","headline":"E-nitiate Biopharma raises $14.4M to develop drugs for dermatosis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}